Bank Of New York Mellon Corp Cue Biopharma, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.41 - $3.74 $51,301 - $79,613	21,287 New	21,287 $76 Million
Q4 2022 Feb 14, 2023	BUY	$2.39 - $3.95 $50,875 - $84,083	21,287 New	21,287 $60,000
Q3 2022 Nov 14, 2022	SELL	$2.23 - $3.37 $22 - $33	-10 Reduced 0.05%	21,329 $48,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $218,694 - $519,947	-87,829 Reduced 80.45%	21,339 $53,000
Q1 2022 May 11, 2022	BUY	$4.41 - $12.28 $10,716 - $29,840	2,430 Added 2.28%	109,168 $533,000
Q4 2021 Feb 11, 2022	SELL	$10.86 - $17.85 $4,322 - $7,104	-398 Reduced 0.37%	106,738 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$10.06 - $15.3 $65,973 - $100,337	6,558 Added 6.52%	107,136 $1.56 Million
Q2 2021 Aug 11, 2021	SELL	$10.9 - $14.53 $102,917 - $137,192	-9,442 Reduced 8.58%	100,578 $0
Q1 2021 May 13, 2021	SELL	$11.2 - $16.09 $55,171 - $79,259	-4,926 Reduced 4.29%	110,020 $0
Q4 2020 Feb 09, 2021	BUY	$11.12 - $16.4 $40,376 - $59,548	3,631 Added 3.26%	114,946 $0
Q3 2020 Nov 12, 2020	SELL	$15.05 - $23.54 $1,128 - $1,765	-75 Reduced 0.07%	111,315 $0
Q2 2020 Aug 12, 2020	BUY	$12.7 - $30.73 $469,531 - $1.14 Million	36,971 Added 49.68%	111,390 $0
Q1 2020 May 06, 2020	BUY	$9.85 - $22.27 $80,149 - $181,210	8,137 Added 12.28%	74,419 $0
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $71,891 - $177,897	10,183 Added 18.15%	66,282 $0
Q3 2019 Nov 07, 2019	SELL	$6.78 - $9.28 $623 - $853	-92 Reduced 0.16%	56,099 $0
Q2 2019 Aug 12, 2019	BUY	$7.18 - $9.65 $1,084 - $1,457	151 Added 0.27%	56,191 $505,000
Q1 2019 May 14, 2019	BUY	$4.7 - $9.29 $20,040 - $39,612	4,264 Added 8.24%	56,040 $433,000
Q4 2018 Feb 11, 2019	BUY	$4.35 - $8.73 $31,633 - $63,484	7,272 Added 16.34%	51,776 $243,000
Q3 2018 Nov 09, 2018	SELL	$7.91 - $11.89 $7 - $11	-1 Reduced -0.0%	44,504 $0
Q2 2018 Aug 06, 2018	BUY	$10.93 - $14.48 $242,962 - $321,875	22,229 Added 99.79%	44,505 $527,000
Q1 2018 May 15, 2018	BUY	$11.63 - $17.25 $259,069 - $384,261	22,276 New	22,276 $313,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account